Parkinsonism & Related Disorders

Papers
(The H4-Index of Parkinsonism & Related Disorders is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Cerebello-thalamofrontal dysconnectivity in paroxysmal kinesigenic dyskinesia: A resting-state fMRI study100
Perry disease in an Argentine family due to the DCTN1 p.G67D variant93
Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?60
Fear among patients with Parkinson's disease and repeated falls: Analysis of skin conductance responses during simulated accidents58
Apomorphine sublingual film for “OFF” episodes in Parkinson’s disease: analysis of baseline factors57
Leigh-like syndrome as a presentation of biallelic variants in DNAJC30 gene with predominant putamen degeneration and limb dystonia50
Critical Appraisal of Economic Evaluation of Biomarkers Used for Screening of Dementia49
A novel summary index derived from Kinect to evaluate the severity of postural abnormalities in patients with Parkinson’s Disease48
Early onset hemichorea-parkinsonism with POLG mutation without external ophthalmoplegia responsive to pallidal DBS46
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease45
White matter connectivity networks predict early dementia conversion in Parkinson’s disease45
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease44
Chorea-Acanthocytosis: A Case Report44
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention43
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.41
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment41
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease40
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease39
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease37
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder37
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome37
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease36
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease33
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school33
Evaluation of mild cognitive impairment in older patients with essential tremor32
Malignant Neuroleptic Syndrome in a Patient with Huntington's Disease30
Early-onset Parkinson's disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: Results from the global burden of disease study 202130
A case of probable Progressive Supranuclear Palsy Frontal type (PSP-F) presenting as psychosis29
APOE carrier status and cognitive outcomes after STN-DBS surgery for Parkinson’s disease.29
Bilateral Hemimasticatory spasm in a patient with hypereosinophilic syndrome29
0.080286026000977